Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Oligodendrocyte (myelinating) 2
[{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff2/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff2/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff3/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff3/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff4/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff4/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff5/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff5/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff6/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff6/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff7/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff7/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff8/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff8/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ff9/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ff9/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffa/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffa/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffb/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffb/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffc/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffc/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffd/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffd/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090ffe/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090ffe/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d090fff/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d090fff/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091000/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091000/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091001/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091001/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091002/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091002/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091003/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091003/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091004/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091004/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091005/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091005/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091006/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091006/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091007/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091007/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091008/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091008/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091009/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091009/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100a/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100a/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100b/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100b/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100c/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100c/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100d/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100d/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100e/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100e/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09100f/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09100f/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091010/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091010/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091011/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091011/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091012/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091012/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091013/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091013/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091014/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091014/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091015/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091015/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091016/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091016/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091017/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091017/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091018/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091018/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091019/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091019/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101a/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101a/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101b/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101b/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101c/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101c/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101d/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101d/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101e/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101e/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d09101f/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d09101f/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091020/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091020/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091021/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091021/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091022/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091022/5d8b843cb1457b0004a60f10.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66e1d84e32fa9c244d091023/5d8b843cb1457b0004a60f10.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66e1d84e32fa9c244d091023/5d8b843cb1457b0004a60f10.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
neuroglia,axon,pns,peripheral nervous system,myelination,myelin,myelin sheath,oligodendrocyte,oligodendroglia,myelinating oligodendrocyte
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
